This inventor holds 2 USPTO granted patents. Top assignee: Beyondspring Pharmaceuticals, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Michel O Steinmetz: Innovator in Cancer Therapeutics
Introduction
Michel O Steinmetz is a prominent inventor based in Villigen, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.
Latest Patents
Steinmetz holds 2 patents related to tubulin binding compounds. His latest patents focus on compounds that can bind to tubulin and activate GEF-H1. These compounds have potential applications in treating cancer, showcasing his commitment to advancing medical science.
Career Highlights
Steinmetz is currently associated with BeyondSpring Pharmaceuticals, Inc., where he continues to push the boundaries of cancer research. His work is characterized by a dedication to finding effective treatments for challenging medical conditions.
Collaborations
Throughout his career, Steinmetz has collaborated with notable professionals in the field, including Santosh Ambadas Khedkar and Lan Huang. These partnerships have enhanced his research and contributed to the development of innovative therapeutic solutions.
Conclusion
Michel O Steinmetz is a key figure in the realm of cancer therapeutics, with a focus on tubulin binding compounds. His contributions are paving the way for new treatment options that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile